Skip to main content


Question for Department of Health and Social Care

UIN 114744, tabled on 12 November 2020

To ask the Secretary of State for Health and Social Care, with reference to the letter of 16 October 2020 from the Minister with responsibility for drugs to the hon. Member for Reigate, what assessment he has made of the implications for his policies of emerging evidence on the use of Psylocybin in the treatment of depression and trauma.

This answer is the replacement for a previous holding answer.

Answered on

14 January 2021

The Government has made no recent assessment of the potential merits of rescheduling psilocybin, which remains a Schedule 1 substance under the Misuse of Drugs Regulations 2001 (the 2001 Regulations).

Ministers continue to take a close interest in any new evidence relating to controlled drugs and they would seek expert advice from the Advisory Council on the Misuse of Drugs before making any amendments to the 2001 Regulations.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.
Interests declared
The Member has declared that they have interests which may be relevant to the subject matter of this question.